Lupin flour may cause peanut allergy like reactions
In a recent study done by Royal Free Hospital, London, lupin flour have been identified as the ingredient that// can cause similar allergic reactions to people who are also allergic to peanuts. Peanuts are known to cause severe allergic symptoms in people. The symptoms of peanut allergy are inflammation of the lips and the tongue, difficulty in breathing, and choking of the throat and...Lupin Gets USFDA Approval For Quinapril Tablets
Pharmaceutical company Lupin Ltd today said it has recieved the final approval from USFDA to market its Abbreviated New Drug Application (ANDA) of hypertension medicine Quinapril in US. // The company informed the Bombay Stock Exchange that the approval is for the multiple dosages of strengths 5 mg, 10 mg, 20 mg and 40 mg. Quinapril is a AB-rated generic equivalent of Pfiz...US Court Rules Against Lupin in Ramipril Patent Case
Pharmaceutical company Lupin Ltd today said that a district court in the US has ruled against the company in a patent infringement suit filed by Sanofi-Aventis and King Pharmaceuticals. // The company informed the Bombay Stock Exchange that the US District Court for the Eastern District of Virginia has issued an opinion following the completion of a trial on Sanofi-Aventis US Patent N...Lupin Gets USFDA Approval for Meloxicam
Lupin Ltd today said it has got the approval of US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Meloxicam tablets used in the treatment of osteoarthritis and rheumatoid arthritis. // The approval is for Meloxicam tablets of strengths of 7.5 mg and 15 mg , the company informed the Bombay Stock Exchange. "The approval of our Meloxi...Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
Pharma company Lupin Ltd today said it has received approval from the Drugs Controller General (India) (DCGI) to conduct Phase II clinical trials for the molecule LL-42 18 (Desoside-P).// The company received permission to continue Phase II clinical trials on the Psoriasis pure compound, LL-42 18, after DCGI found the clinical Phase I data of the molecule to be satisfactory....